Literature DB >> 1629898

Cleavage of immunoglobulin A1, A2 and G by proteases from clinical isolates of Pasteurella multocida.

P Pouedras1, P M Andre, P Y Donnio, J L Avril.   

Abstract

Several Pasteurella multocida strains were examined for their ability to produce extracellular enzymes that cleave immunoglobulin A and G (Ig A and Ig G) molecules. Two strains isolated from human pulmonary and genital infections produced proteases that cleaved human IgA and IgG, colostral IgA and human myeloma IgA1 and IgA2. Human IgM was not degraded by these enzymes. Examination of cleavage digests showed two main fragments with different electrophoretic mobilities. The two P. multocida strains produced a protease that cleaved IgA and IgG heavy chains outside the hinge region, and differed in this respect from the hinge-cutting proteases of other bacteria. Protease production may be a virulence mechanism for P. multocida strains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629898     DOI: 10.1099/00222615-37-2-128

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  4 in total

1.  Evidence of bovine immunoglobulin G1 (IgG1) protease activity in partially purified culture supernate of Pasteurella haemolytica A1.

Authors:  C W Lee; P E Shewen
Journal:  Can J Vet Res       Date:  1996-04       Impact factor: 1.310

2.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Oligoarticular Hemarthroses and Osteomyelitis Complicating Pasteurella Meningitis in an Infant.

Authors:  Charles Nathan Nessle; Allison K Black; Justin Farge; Victoria A Statler
Journal:  Children (Basel)       Date:  2017-10-16

Review 4.  Serum IgA Fc effector functions in infectious disease and cancer.

Authors:  Samantha K Davis; Kevin J Selva; Stephen J Kent; Amy W Chung
Journal:  Immunol Cell Biol       Date:  2020-01-19       Impact factor: 5.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.